JP2010533645A5

JP2010533645A5 -

Download PDF

Info

Publication number: JP2010533645A5
Authority: JP; Japan
Prior art keywords: cdcl; nmr; mhz; alkyl; compound according
Prior art date: 2008-05-30
Legal status : Pending

Application number

JP2010510368A

Other languages

English (en)

Japanese (ja)

Other versions

JP2010533645A (ja

Filing date

2008-05-30

Publication date

2012-07-05

2008-05-30 Application filed filed Critical

2008-05-30 Priority claimed from PCT/US2008/006913 external-priority patent/WO2008150492A1/en

2010-10-28 Publication of JP2010533645A publication Critical patent/JP2010533645A/ja

2012-07-05 Publication of JP2010533645A5 publication Critical patent/JP2010533645A5/ja

Status Pending legal-status Critical Current

Links

150000001875 compounds Chemical class 0.000 claims description 227
108010046094 fatty-acid amide hydrolase Proteins 0.000 claims description 69
102100029111 Fatty-acid amide hydrolase 1 Human genes 0.000 claims description 55
239000000203 mixture Substances 0.000 claims description 55
125000000217 alkyl group Chemical group 0.000 claims description 31
239000000651 prodrug Substances 0.000 claims description 23
229940002612 prodrug Drugs 0.000 claims description 23
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 22
150000003839 salts Chemical class 0.000 claims description 21
125000003118 aryl group Chemical group 0.000 claims description 17
230000002401 inhibitory effect Effects 0.000 claims description 14
230000005764 inhibitory process Effects 0.000 claims description 13
239000002207 metabolite Substances 0.000 claims description 9
239000004480 active ingredient Substances 0.000 claims description 8
239000008194 pharmaceutical composition Substances 0.000 claims description 8
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 7
229910052799 carbon Inorganic materials 0.000 claims description 7
230000003197 catalytic effect Effects 0.000 claims description 7
125000001153 fluoro group Chemical group F* 0.000 claims description 7
125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 6
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 6
UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 claims description 6
125000001072 heteroaryl group Chemical group 0.000 claims description 6
125000002971 oxazolyl group Chemical group 0.000 claims description 6
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims description 5
125000001309 chloro group Chemical group Cl* 0.000 claims description 5
125000004076 pyridyl group Chemical group 0.000 claims description 5
BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims description 4
125000001246 bromo group Chemical group Br* 0.000 claims description 4
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
239000003937 drug carrier Substances 0.000 claims description 4
229910052731 fluorine Inorganic materials 0.000 claims description 4
125000002541 furyl group Chemical group 0.000 claims description 4
125000001475 halogen functional group Chemical group 0.000 claims description 4
125000002883 imidazolyl group Chemical group 0.000 claims description 4
229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims description 4
125000003373 pyrazinyl group Chemical group 0.000 claims description 4
125000002098 pyridazinyl group Chemical group 0.000 claims description 4
125000000714 pyrimidinyl group Chemical group 0.000 claims description 4
239000002904 solvent Substances 0.000 claims description 4
125000003831 tetrazolyl group Chemical group 0.000 claims description 4
125000001544 thienyl group Chemical group 0.000 claims description 4
TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 claims description 3
229960001138 acetylsalicylic acid Drugs 0.000 claims description 3
229960002870 gabapentin Drugs 0.000 claims description 3
125000005843 halogen group Chemical group 0.000 claims description 3
239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims description 3
229960005489 paracetamol Drugs 0.000 claims description 3
AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 claims description 3
229960001233 pregabalin Drugs 0.000 claims description 3
229960004380 tramadol Drugs 0.000 claims description 3
TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 claims description 3
125000001425 triazolyl group Chemical group 0.000 claims description 3
239000013543 active substance Substances 0.000 claims description 2
101000937693 Homo sapiens Fatty acid 2-hydroxylase Proteins 0.000 claims 1
101000918494 Homo sapiens Fatty-acid amide hydrolase 1 Proteins 0.000 claims 1
238000000034 method Methods 0.000 description 171
229910004298 SiO 2 Inorganic materials 0.000 description 118
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 115
239000007787 solid Substances 0.000 description 90
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 86
LUMKXMDGONYZHO-UHFFFAOYSA-N 5-pyridin-2-yl-1,3-oxazole Chemical compound O1C=NC=C1C1=CC=CC=N1 LUMKXMDGONYZHO-UHFFFAOYSA-N 0.000 description 75
239000011541 reaction mixture Substances 0.000 description 75
239000000243 solution Substances 0.000 description 71
238000004440 column chromatography Methods 0.000 description 65
239000000460 chlorine Substances 0.000 description 59
239000011734 sodium Substances 0.000 description 58
239000003112 inhibitor Substances 0.000 description 53
239000003921 oil Substances 0.000 description 46
235000019198 oils Nutrition 0.000 description 46
125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 40
235000019439 ethyl acetate Nutrition 0.000 description 38
125000004287 oxazol-2-yl group Chemical group [H]C1=C([H])N=C(*)O1 0.000 description 38
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 36
-1 lipid amides Chemical class 0.000 description 34
229920006395 saturated elastomer Polymers 0.000 description 34
238000003756 stirring Methods 0.000 description 33
239000012044 organic layer Substances 0.000 description 32
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 30
238000000746 purification Methods 0.000 description 29
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 28
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical class CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 26
238000011282 treatment Methods 0.000 description 26
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
FATBGEAMYMYZAF-KTKRTIGZSA-N oleamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(N)=O FATBGEAMYMYZAF-KTKRTIGZSA-N 0.000 description 24
230000000694 effects Effects 0.000 description 23
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 21
238000006243 chemical reaction Methods 0.000 description 20
238000006467 substitution reaction Methods 0.000 description 20
239000003795 chemical substances by application Substances 0.000 description 19
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 18
150000001408 amides Chemical class 0.000 description 18
201000010099 disease Diseases 0.000 description 18
208000035475 disorder Diseases 0.000 description 18
125000001424 substituent group Chemical group 0.000 description 18
239000000725 suspension Substances 0.000 description 18
239000002253 acid Substances 0.000 description 17
150000001412 amines Chemical class 0.000 description 17
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
LGEQQWMQCRIYKG-DOFZRALJSA-N anandamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO LGEQQWMQCRIYKG-DOFZRALJSA-N 0.000 description 15
239000000047 product Substances 0.000 description 15
239000011780 sodium chloride Substances 0.000 description 15
238000004587 chromatography analysis Methods 0.000 description 14
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
239000003814 drug Substances 0.000 description 13
235000019441 ethanol Nutrition 0.000 description 13
WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 12
150000001345 alkine derivatives Chemical class 0.000 description 12
239000012230 colorless oil Substances 0.000 description 12
229940079593 drug Drugs 0.000 description 11
FATBGEAMYMYZAF-UHFFFAOYSA-N oleicacidamide-heptaglycolether Natural products CCCCCCCCC=CCCCCCCCC(N)=O FATBGEAMYMYZAF-UHFFFAOYSA-N 0.000 description 11
MOTUJBWFEMQPFY-UHFFFAOYSA-N 1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one Chemical compound O1C(C(CCCCC#C)=O)=NC=C1C1=CC=CC=N1 MOTUJBWFEMQPFY-UHFFFAOYSA-N 0.000 description 10
208000002193 Pain Diseases 0.000 description 10
125000002887 hydroxy group Chemical group [H]O* 0.000 description 10
239000012074 organic phase Substances 0.000 description 10
230000036407 pain Effects 0.000 description 10
LCQJRGFWCONPKG-UHFFFAOYSA-N 1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-trimethylsilylhept-6-yn-1-one Chemical compound O1C(C(=O)CCCCC#C[Si](C)(C)C)=NC=C1C1=CC=CC=N1 LCQJRGFWCONPKG-UHFFFAOYSA-N 0.000 description 9
NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 9
QWKHLSRRDRKRHH-UHFFFAOYSA-N 6-phenylsulfanyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCCCCSC1=CC=CC=C1 QWKHLSRRDRKRHH-UHFFFAOYSA-N 0.000 description 9
ILOIOIGZFHGSMS-UHFFFAOYSA-N 7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCCCCCC1=CC=CC=C1 ILOIOIGZFHGSMS-UHFFFAOYSA-N 0.000 description 9
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
LGEQQWMQCRIYKG-UHFFFAOYSA-N arachidonic acid ethanolamide Natural products CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCO LGEQQWMQCRIYKG-UHFFFAOYSA-N 0.000 description 9
230000015572 biosynthetic process Effects 0.000 description 9
150000001732 carboxylic acid derivatives Chemical class 0.000 description 9
102000004190 Enzymes Human genes 0.000 description 8
108090000790 Enzymes Proteins 0.000 description 8
125000005842 heteroatom Chemical class 0.000 description 8
238000001727 in vivo Methods 0.000 description 8
230000001404 mediated effect Effects 0.000 description 8
229910052717 sulfur Inorganic materials 0.000 description 8
NLMGKBWZZZUXAF-UHFFFAOYSA-N 5-benzylsulfanyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCCCSCC1=CC=CC=C1 NLMGKBWZZZUXAF-UHFFFAOYSA-N 0.000 description 7
AJTFTOJFTFVQHK-UHFFFAOYSA-N 7-(3-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound ClC1=CC=CC(CCCCCCC(=O)C=2OC(=CN=2)C=2N=CC=CC=2)=C1 AJTFTOJFTFVQHK-UHFFFAOYSA-N 0.000 description 7
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 7
125000002252 acyl group Chemical group 0.000 description 7
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 7
230000002209 hydrophobic effect Effects 0.000 description 7
229910052763 palladium Inorganic materials 0.000 description 7
239000008177 pharmaceutical agent Substances 0.000 description 7
239000000546 pharmaceutical excipient Substances 0.000 description 7
239000000126 substance Substances 0.000 description 7
208000024891 symptom Diseases 0.000 description 7
238000003786 synthesis reaction Methods 0.000 description 7
230000001225 therapeutic effect Effects 0.000 description 7
ZSJUSXPDIILCLH-UHFFFAOYSA-N 2-(4-phenylbutylsulfanyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CSCCCCC1=CC=CC=C1 ZSJUSXPDIILCLH-UHFFFAOYSA-N 0.000 description 6
CAKYMZGCDUJSHV-UHFFFAOYSA-N 7-(3-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one Chemical compound FC1=CC=CC(C#CCCCCC(=O)C=2OC(=CN=2)C=2N=CC=CC=2)=C1 CAKYMZGCDUJSHV-UHFFFAOYSA-N 0.000 description 6
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
208000019901 Anxiety disease Diseases 0.000 description 6
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
102000004157 Hydrolases Human genes 0.000 description 6
108090000604 Hydrolases Proteins 0.000 description 6
108090001060 Lipase Proteins 0.000 description 6
102000004882 Lipase Human genes 0.000 description 6
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
230000036506 anxiety Effects 0.000 description 6
238000003556 assay Methods 0.000 description 6
239000003153 chemical reaction reagent Substances 0.000 description 6
125000000468 ketone group Chemical group 0.000 description 6
XCQLQCMUFOUXNW-UHFFFAOYSA-N methyl 4-oxo-4-(5-pyridin-2-yl-1,3-oxazol-2-yl)butanoate Chemical compound O1C(C(=O)CCC(=O)OC)=NC=C1C1=CC=CC=N1 XCQLQCMUFOUXNW-UHFFFAOYSA-N 0.000 description 6
CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 6
238000010992 reflux Methods 0.000 description 6
238000012216 screening Methods 0.000 description 6
ACFQPEYROBESHL-UHFFFAOYSA-N 2-(4-phenylbutylsulfanyl)acetic acid Chemical compound OC(=O)CSCCCCC1=CC=CC=C1 ACFQPEYROBESHL-UHFFFAOYSA-N 0.000 description 5
NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical class CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 5
CGCSZFSHHNBIEP-WAYWQWQTSA-N 4-[(z)-hex-1-enyl]benzonitrile Chemical compound CCCC\C=C/C1=CC=C(C#N)C=C1 CGCSZFSHHNBIEP-WAYWQWQTSA-N 0.000 description 5
AKJYYMZJBSAQRW-UHFFFAOYSA-N 5-benzylsulfanylpentanoic acid Chemical compound OC(=O)CCCCSCC1=CC=CC=C1 AKJYYMZJBSAQRW-UHFFFAOYSA-N 0.000 description 5
ODQCXALXZCGYKU-UHFFFAOYSA-N 7-(3-methylsulfanylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound CSC1=CC=CC(CCCCCCC(=O)C=2OC(=CN=2)C=2N=CC=CC=2)=C1 ODQCXALXZCGYKU-UHFFFAOYSA-N 0.000 description 5
JPUOUZLSBPJXEV-UHFFFAOYSA-N 7-(4-methylsulfanylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound C1=CC(SC)=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 JPUOUZLSBPJXEV-UHFFFAOYSA-N 0.000 description 5
JZFWIDYYQVMFRC-UHFFFAOYSA-N 7-phenyl-5-tri(propan-2-yl)silyloxyheptan-1-ol Chemical compound OCCCCC(O[Si](C(C)C)(C(C)C)C(C)C)CCC1=CC=CC=C1 JZFWIDYYQVMFRC-UHFFFAOYSA-N 0.000 description 5
RQYDQLCDKZGZFP-UHFFFAOYSA-N 7-thiophen-2-ylheptanoic acid Chemical compound OC(=O)CCCCCCC1=CC=CS1 RQYDQLCDKZGZFP-UHFFFAOYSA-N 0.000 description 5
150000001299 aldehydes Chemical class 0.000 description 5
230000036592 analgesia Effects 0.000 description 5
210000004027 cell Anatomy 0.000 description 5
230000002860 competitive effect Effects 0.000 description 5
239000012043 crude product Substances 0.000 description 5
206010015037 epilepsy Diseases 0.000 description 5
150000002148 esters Chemical class 0.000 description 5
230000001965 increasing effect Effects 0.000 description 5
DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 5
RKOGTMPBDGPBFH-UHFFFAOYSA-N methyl 5-oxo-5-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentanoate Chemical compound O1C(C(=O)CCCC(=O)OC)=NC=C1C1=CC=CC=N1 RKOGTMPBDGPBFH-UHFFFAOYSA-N 0.000 description 5
150000004702 methyl esters Chemical class 0.000 description 5
MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 5
230000003389 potentiating effect Effects 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
125000006413 ring segment Chemical group 0.000 description 5
208000019116 sleep disease Diseases 0.000 description 5
230000009897 systematic effect Effects 0.000 description 5
PSELCIMQRLODQE-UHFFFAOYSA-N tert-butyl 6-bromohexanoate Chemical compound CC(C)(C)OC(=O)CCCCCBr PSELCIMQRLODQE-UHFFFAOYSA-N 0.000 description 5
HPJOGBALSGPNKE-UHFFFAOYSA-N 1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone Chemical compound O1C(C(=O)C)=NC=C1C1=CC=CC=N1 HPJOGBALSGPNKE-UHFFFAOYSA-N 0.000 description 4
HHCOCKSGAZJTSF-UHFFFAOYSA-N 2-(4-phenylbutoxy)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)COCCCCC1=CC=CC=C1 HHCOCKSGAZJTSF-UHFFFAOYSA-N 0.000 description 4
SUSBNVUPOYOEEU-UHFFFAOYSA-N 2-(4-phenylbutoxy)acetic acid Chemical compound OC(=O)COCCCCC1=CC=CC=C1 SUSBNVUPOYOEEU-UHFFFAOYSA-N 0.000 description 4
UPBDZGUJJJWEKJ-ALCCZGGFSA-N 3-[(z)-hex-1-enyl]benzaldehyde Chemical compound CCCC\C=C/C1=CC=CC(C=O)=C1 UPBDZGUJJJWEKJ-ALCCZGGFSA-N 0.000 description 4
IVDLVBMNRHXKAX-ALCCZGGFSA-N 3-[(z)-hex-1-enyl]benzonitrile Chemical compound CCCC\C=C/C1=CC=CC(C#N)=C1 IVDLVBMNRHXKAX-ALCCZGGFSA-N 0.000 description 4
JGZPDVMBIBYCQR-WAYWQWQTSA-N 4-[(z)-hex-1-enyl]benzaldehyde Chemical compound CCCC\C=C/C1=CC=C(C=O)C=C1 JGZPDVMBIBYCQR-WAYWQWQTSA-N 0.000 description 4
KMWBCGYYQBQMCP-UHFFFAOYSA-N 5-[benzyl(methyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one Chemical compound C=1C=CC=CC=1CN(C)CCCCC(=O)C(O1)=NC=C1C1=CC=CC=N1 KMWBCGYYQBQMCP-UHFFFAOYSA-N 0.000 description 4
KDNUJAZVJXKPNI-UHFFFAOYSA-N 5-phenylmethoxypentanal Chemical compound O=CCCCCOCC1=CC=CC=C1 KDNUJAZVJXKPNI-UHFFFAOYSA-N 0.000 description 4
KAXKZDMCTYUQAY-UHFFFAOYSA-N 6-bromo-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one Chemical compound O1C(C(=O)CCCCCBr)=NC=C1C1=CC=CC=N1 KAXKZDMCTYUQAY-UHFFFAOYSA-N 0.000 description 4
LPAASVMIRJIDQI-UHFFFAOYSA-N 6-phenylsulfanylhexanoic acid Chemical compound OC(=O)CCCCCSC1=CC=CC=C1 LPAASVMIRJIDQI-UHFFFAOYSA-N 0.000 description 4
JLBAXVZDDSWVAO-UHFFFAOYSA-N 7-(2-methylphenyl)heptanoic acid Chemical compound CC1=CC=CC=C1CCCCCCC(O)=O JLBAXVZDDSWVAO-UHFFFAOYSA-N 0.000 description 4
VFFCAWRKSCCZHW-UHFFFAOYSA-N 7-(2-methylsulfanylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound CSC1=CC=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 VFFCAWRKSCCZHW-UHFFFAOYSA-N 0.000 description 4
KEBNWMOWLIFASI-UHFFFAOYSA-N 7-(3-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one Chemical compound ClC1=CC=CC(C#CCCCCC(=O)C=2OC(=CN=2)C=2N=CC=CC=2)=C1 KEBNWMOWLIFASI-UHFFFAOYSA-N 0.000 description 4
GQFMUNROJMPZCY-UHFFFAOYSA-N 7-(3-methylsulfanylphenyl)heptanoic acid Chemical compound CSC1=CC=CC(CCCCCCC(O)=O)=C1 GQFMUNROJMPZCY-UHFFFAOYSA-N 0.000 description 4
TVDVQAYAQIUZSR-UHFFFAOYSA-N 7-(4-hexylphenyl)heptanoic acid Chemical compound CCCCCCC1=CC=C(CCCCCCC(O)=O)C=C1 TVDVQAYAQIUZSR-UHFFFAOYSA-N 0.000 description 4
GVQILVWPWHFVIE-UHFFFAOYSA-N 7-(4-methoxyphenyl)heptanoic acid Chemical compound COC1=CC=C(CCCCCCC(O)=O)C=C1 GVQILVWPWHFVIE-UHFFFAOYSA-N 0.000 description 4
DOQYHNYWFHIVPS-UHFFFAOYSA-N 7-naphthalen-2-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound C=1C=C2C=CC=CC2=CC=1CCCCCCC(=O)C(O1)=NC=C1C1=CC=CC=N1 DOQYHNYWFHIVPS-UHFFFAOYSA-N 0.000 description 4
QUKCZLYRLZOFPW-UHFFFAOYSA-N 7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-5-tri(propan-2-yl)silyloxyheptan-1-one Chemical compound C=1C=CC=CC=1CCC(O[Si](C(C)C)(C(C)C)C(C)C)CCCC(=O)C(O1)=NC=C1C1=CC=CC=N1 QUKCZLYRLZOFPW-UHFFFAOYSA-N 0.000 description 4
SVWJFOULZBYEJU-UHFFFAOYSA-N 7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-tri(propan-2-yl)silyloxyheptan-1-one Chemical compound C=1C=CC=CC=1C(O[Si](C(C)C)(C(C)C)C(C)C)CCCCCC(=O)C(O1)=NC=C1C1=CC=CC=N1 SVWJFOULZBYEJU-UHFFFAOYSA-N 0.000 description 4
KMFIFAWVCJMYRR-UHFFFAOYSA-N 7-phenyl-5-tri(propan-2-yl)silyloxyheptanoic acid Chemical compound OC(=O)CCCC(O[Si](C(C)C)(C(C)C)C(C)C)CCC1=CC=CC=C1 KMFIFAWVCJMYRR-UHFFFAOYSA-N 0.000 description 4
ARWDLKBMRSXSFZ-UHFFFAOYSA-N 7-phenyl-7-tri(propan-2-yl)silyloxyheptanoic acid Chemical compound OC(=O)CCCCCC(O[Si](C(C)C)(C(C)C)C(C)C)C1=CC=CC=C1 ARWDLKBMRSXSFZ-UHFFFAOYSA-N 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
208000030814 Eating disease Diseases 0.000 description 4
208000019454 Feeding and Eating disease Diseases 0.000 description 4
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
206010061218 Inflammation Diseases 0.000 description 4
VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 4
206010028980 Neoplasm Diseases 0.000 description 4
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
108010026552 Proteome Proteins 0.000 description 4
229920002472 Starch Polymers 0.000 description 4
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
ROFVXGGUISEHAM-UHFFFAOYSA-N URB597 Chemical compound NC(=O)C1=CC=CC(C=2C=C(OC(=O)NC3CCCCC3)C=CC=2)=C1 ROFVXGGUISEHAM-UHFFFAOYSA-N 0.000 description 4
150000007513 acids Chemical class 0.000 description 4
230000009471 action Effects 0.000 description 4
235000001014 amino acid Nutrition 0.000 description 4
230000004888 barrier function Effects 0.000 description 4
239000002585 base Substances 0.000 description 4
230000008901 benefit Effects 0.000 description 4
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
201000011510 cancer Diseases 0.000 description 4
229930003827 cannabinoid Natural products 0.000 description 4
239000003557 cannabinoid Substances 0.000 description 4
HJVWHQIIAWBCFX-UHFFFAOYSA-N cyclopropyl-(5-pyridin-2-yl-1,3-oxazol-2-yl)methanone Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)C1CC1 HJVWHQIIAWBCFX-UHFFFAOYSA-N 0.000 description 4
NKLCNNUWBJBICK-UHFFFAOYSA-N dess–martin periodinane Chemical compound C1=CC=C2I(OC(=O)C)(OC(C)=O)(OC(C)=O)OC(=O)C2=C1 NKLCNNUWBJBICK-UHFFFAOYSA-N 0.000 description 4
235000014632 disordered eating Nutrition 0.000 description 4
CBLRKMHGDTXYKT-UHFFFAOYSA-N ethyl 7-hydroxy-7-phenylheptanoate Chemical compound CCOC(=O)CCCCCC(O)C1=CC=CC=C1 CBLRKMHGDTXYKT-UHFFFAOYSA-N 0.000 description 4
239000003940 fatty acid amidase inhibitor Substances 0.000 description 4
239000000706 filtrate Substances 0.000 description 4
238000009472 formulation Methods 0.000 description 4
230000004054 inflammatory process Effects 0.000 description 4
239000007788 liquid Substances 0.000 description 4
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
MEJUZYNOMWOYLT-UHFFFAOYSA-N methyl 2-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzoate Chemical compound COC(=O)C1=CC=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 MEJUZYNOMWOYLT-UHFFFAOYSA-N 0.000 description 4
YYOSOHHWGJEOQD-UHFFFAOYSA-N methyl 3-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzoate Chemical compound COC(=O)C1=CC=CC(CCCCCCC(=O)C=2OC(=CN=2)C=2N=CC=CC=2)=C1 YYOSOHHWGJEOQD-UHFFFAOYSA-N 0.000 description 4
DOQPJISTYSHXTI-UHFFFAOYSA-N methyl 4-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 DOQPJISTYSHXTI-UHFFFAOYSA-N 0.000 description 4
201000006417 multiple sclerosis Diseases 0.000 description 4
SASNBVQSOZSTPD-UHFFFAOYSA-N n-methylphenethylamine Chemical compound CNCCC1=CC=CC=C1 SASNBVQSOZSTPD-UHFFFAOYSA-N 0.000 description 4
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
230000000069 prophylactic effect Effects 0.000 description 4
235000019698 starch Nutrition 0.000 description 4
239000000758 substrate Substances 0.000 description 4
239000011593 sulfur Substances 0.000 description 4
ANJQCZVXKMNXIE-UHFFFAOYSA-N tert-butyl n-[3-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=CC(CCCCCCC(=O)C=2OC(=CN=2)C=2N=CC=CC=2)=C1 ANJQCZVXKMNXIE-UHFFFAOYSA-N 0.000 description 4
ZWKZJZYJZGLUQV-UHFFFAOYSA-N tert-butyl n-[4-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]phenyl]carbamate Chemical compound C1=CC(NC(=O)OC(C)(C)C)=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 ZWKZJZYJZGLUQV-UHFFFAOYSA-N 0.000 description 4
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
BMAGTENQWOOMSK-UHFFFAOYSA-N (1-phenyl-7-phenylmethoxyheptan-2-yl)oxy-tri(propan-2-yl)silane Chemical compound C=1C=CC=CC=1CC(O[Si](C(C)C)(C(C)C)C(C)C)CCCCCOCC1=CC=CC=C1 BMAGTENQWOOMSK-UHFFFAOYSA-N 0.000 description 3
UXXPVAXHOVKBBZ-UHFFFAOYSA-N (1-phenyl-7-phenylmethoxyheptan-3-yl)oxy-tri(propan-2-yl)silane Chemical compound C=1C=CC=CC=1CCC(O[Si](C(C)C)(C(C)C)C(C)C)CCCCOCC1=CC=CC=C1 UXXPVAXHOVKBBZ-UHFFFAOYSA-N 0.000 description 3
DCHDDAJCGPQNFI-UHFFFAOYSA-N (1-phenyl-7-phenylmethoxyheptan-4-yl)oxy-tri(propan-2-yl)silane Chemical compound C=1C=CC=CC=1CCCC(O[Si](C(C)C)(C(C)C)C(C)C)CCCOCC1=CC=CC=C1 DCHDDAJCGPQNFI-UHFFFAOYSA-N 0.000 description 3
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
VYGSYWKKZIMLJG-UHFFFAOYSA-N 1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-thiophen-2-ylheptan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCCCCCC1=CC=CS1 VYGSYWKKZIMLJG-UHFFFAOYSA-N 0.000 description 3
BBFQYOOSPUJNBB-UHFFFAOYSA-N 1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-thiophen-3-ylheptan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCCCCCC=1C=CSC=1 BBFQYOOSPUJNBB-UHFFFAOYSA-N 0.000 description 3
GITGCQFUAIHBAT-UHFFFAOYSA-N 2-(4-phenylbutylsulfinyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CS(=O)CCCCC1=CC=CC=C1 GITGCQFUAIHBAT-UHFFFAOYSA-N 0.000 description 3
WAFLPSZQYRJHGG-UHFFFAOYSA-N 2-(4-phenylbutylsulfonyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CS(=O)(=O)CCCCC1=CC=CC=C1 WAFLPSZQYRJHGG-UHFFFAOYSA-N 0.000 description 3
WRGRJTCLWCIYNZ-UHFFFAOYSA-N 2-(oxiran-2-yl)-5-pyridin-2-yl-1,3-oxazole Chemical compound C1OC1C1=NC=C(C=2N=CC=CC=2)O1 WRGRJTCLWCIYNZ-UHFFFAOYSA-N 0.000 description 3
AJKMVLGJYOWCGX-UHFFFAOYSA-N 2-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzoic acid Chemical compound OC(=O)C1=CC=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 AJKMVLGJYOWCGX-UHFFFAOYSA-N 0.000 description 3
MKVLXIACPLGLLP-UHFFFAOYSA-N 2-chloro-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone Chemical compound O1C(C(=O)CCl)=NC=C1C1=CC=CC=N1 MKVLXIACPLGLLP-UHFFFAOYSA-N 0.000 description 3
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
SQVFAGRJQCCLCB-UHFFFAOYSA-N 3-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzoic acid Chemical compound OC(=O)C1=CC=CC(CCCCCCC(=O)C=2OC(=CN=2)C=2N=CC=CC=2)=C1 SQVFAGRJQCCLCB-UHFFFAOYSA-N 0.000 description 3
LGDLBHZNLHEDMX-UHFFFAOYSA-N 3-[methyl(3-phenylpropyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCN(C)CCCC1=CC=CC=C1 LGDLBHZNLHEDMX-UHFFFAOYSA-N 0.000 description 3
125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 3
WINBMHQQBYBMDV-UHFFFAOYSA-N 3-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CC(O)CCCCC1=CC=CC=C1 WINBMHQQBYBMDV-UHFFFAOYSA-N 0.000 description 3
HLSBHAXEDUSQLL-UHFFFAOYSA-N 4-[methyl(2-phenylethyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)butan-1-one Chemical compound C=1C=CC=CC=1CCN(C)CCCC(=O)C(O1)=NC=C1C1=CC=CC=N1 HLSBHAXEDUSQLL-UHFFFAOYSA-N 0.000 description 3
WPCBMXLUQSPZRO-UHFFFAOYSA-N 6-(benzenesulfinyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCCCCS(=O)C1=CC=CC=C1 WPCBMXLUQSPZRO-UHFFFAOYSA-N 0.000 description 3
WZLKAAQFNVCYKK-UHFFFAOYSA-N 6-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound C=1C=CC=CC=1CC(O)CCCCC(=O)C(O1)=NC=C1C1=CC=CC=N1 WZLKAAQFNVCYKK-UHFFFAOYSA-N 0.000 description 3
OOPSZFOFVBJXMF-UHFFFAOYSA-N 7-(2,3-dichlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound ClC1=CC=CC(CCCCCCC(=O)C=2OC(=CN=2)C=2N=CC=CC=2)=C1Cl OOPSZFOFVBJXMF-UHFFFAOYSA-N 0.000 description 3
BGLMHWMNTFYACR-UHFFFAOYSA-N 7-(2-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one Chemical compound FC1=CC=CC=C1C#CCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 BGLMHWMNTFYACR-UHFFFAOYSA-N 0.000 description 3
JPUWBGZATHHUFT-UHFFFAOYSA-N 7-(2-methoxyphenyl)heptanoic acid Chemical compound COC1=CC=CC=C1CCCCCCC(O)=O JPUWBGZATHHUFT-UHFFFAOYSA-N 0.000 description 3
MDQSFQJGZXYZFQ-UHFFFAOYSA-N 7-(2-methylsulfanylphenyl)heptanoic acid Chemical compound CSC1=CC=CC=C1CCCCCCC(O)=O MDQSFQJGZXYZFQ-UHFFFAOYSA-N 0.000 description 3
NVJFYDZVXWUPCQ-UHFFFAOYSA-N 7-(3-hexylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound CCCCCCC1=CC=CC(CCCCCCC(=O)C=2OC(=CN=2)C=2N=CC=CC=2)=C1 NVJFYDZVXWUPCQ-UHFFFAOYSA-N 0.000 description 3
FPUOYDRZJYIBBR-UHFFFAOYSA-N 7-(3-hexylphenyl)heptanoic acid Chemical compound CCCCCCC1=CC=CC(CCCCCCC(O)=O)=C1 FPUOYDRZJYIBBR-UHFFFAOYSA-N 0.000 description 3
DZAIVACWSOJCGR-UHFFFAOYSA-N 7-(3-methoxyphenyl)heptanoic acid Chemical compound COC1=CC=CC(CCCCCCC(O)=O)=C1 DZAIVACWSOJCGR-UHFFFAOYSA-N 0.000 description 3
UKZSDGJQSPWZML-UHFFFAOYSA-N 7-(3-methylphenyl)heptanoic acid Chemical compound CC1=CC=CC(CCCCCCC(O)=O)=C1 UKZSDGJQSPWZML-UHFFFAOYSA-N 0.000 description 3
QNJLPQOXOKUJNQ-UHFFFAOYSA-N 7-(3-methylsulfonylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound CS(=O)(=O)C1=CC=CC(CCCCCCC(=O)C=2OC(=CN=2)C=2N=CC=CC=2)=C1 QNJLPQOXOKUJNQ-UHFFFAOYSA-N 0.000 description 3
VIZMXSRZYDNGKU-UHFFFAOYSA-N 7-(4-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one Chemical compound C1=CC(Cl)=CC=C1C#CCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 VIZMXSRZYDNGKU-UHFFFAOYSA-N 0.000 description 3
CTRAZMWATUGBEI-UHFFFAOYSA-N 7-(4-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound C1=CC(Cl)=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 CTRAZMWATUGBEI-UHFFFAOYSA-N 0.000 description 3
BVHCIAJWTUVEHX-UHFFFAOYSA-N 7-(4-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one Chemical compound C1=CC(F)=CC=C1C#CCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 BVHCIAJWTUVEHX-UHFFFAOYSA-N 0.000 description 3
KNXFTSUMHKYJME-UHFFFAOYSA-N 7-(4-hexylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound C1=CC(CCCCCC)=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 KNXFTSUMHKYJME-UHFFFAOYSA-N 0.000 description 3
IULVPTNFONBXHK-UHFFFAOYSA-N 7-(4-methylphenyl)heptanoic acid Chemical compound CC1=CC=C(CCCCCCC(O)=O)C=C1 IULVPTNFONBXHK-UHFFFAOYSA-N 0.000 description 3
OSHITKJNKPKPIB-UHFFFAOYSA-N 7-(4-methylsulfanylphenyl)heptanoic acid Chemical compound CSC1=CC=C(CCCCCCC(O)=O)C=C1 OSHITKJNKPKPIB-UHFFFAOYSA-N 0.000 description 3
KYPMNYDXOVUKHE-UHFFFAOYSA-N 7-(4-nitrophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound C1=CC([N+](=O)[O-])=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 KYPMNYDXOVUKHE-UHFFFAOYSA-N 0.000 description 3
UNQRPHQCMZCRIG-UHFFFAOYSA-N 7-naphthalen-1-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound C=1C=CC2=CC=CC=C2C=1CCCCCCC(=O)C(O1)=NC=C1C1=CC=CC=N1 UNQRPHQCMZCRIG-UHFFFAOYSA-N 0.000 description 3
OTYCUXCZGNDFQD-UHFFFAOYSA-N 7-naphthalen-1-ylheptanoic acid Chemical compound C1=CC=C2C(CCCCCCC(=O)O)=CC=CC2=C1 OTYCUXCZGNDFQD-UHFFFAOYSA-N 0.000 description 3
BZXDQVOCNYXJKP-UHFFFAOYSA-N 7-naphthalen-2-ylheptanoic acid Chemical compound C1=CC=CC2=CC(CCCCCCC(=O)O)=CC=C21 BZXDQVOCNYXJKP-UHFFFAOYSA-N 0.000 description 3
FFPCMOMYRQIYFP-UHFFFAOYSA-N 7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-4-tri(propan-2-yl)silyloxyheptan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCC(O[Si](C(C)C)(C(C)C)C(C)C)CCCC1=CC=CC=C1 FFPCMOMYRQIYFP-UHFFFAOYSA-N 0.000 description 3
VRXJNUYQHIJMEJ-UHFFFAOYSA-N 7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-6-tri(propan-2-yl)silyloxyheptan-1-one Chemical compound C=1C=CC=CC=1CC(O[Si](C(C)C)(C(C)C)C(C)C)CCCCC(=O)C(O1)=NC=C1C1=CC=CC=N1 VRXJNUYQHIJMEJ-UHFFFAOYSA-N 0.000 description 3
YZZBBEFROLKDHB-UHFFFAOYSA-N 7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptane-1,3-diol Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(O)CC(O)CCCCC1=CC=CC=C1 YZZBBEFROLKDHB-UHFFFAOYSA-N 0.000 description 3
GZKHWHYBCNCVCJ-UHFFFAOYSA-N 7-phenyl-4-tri(propan-2-yl)silyloxyheptan-1-ol Chemical compound CC(C)[Si](C(C)C)(C(C)C)OC(CCCO)CCCC1=CC=CC=C1 GZKHWHYBCNCVCJ-UHFFFAOYSA-N 0.000 description 3
DWMXFJUPTIHQGQ-UHFFFAOYSA-N 7-phenyl-4-tri(propan-2-yl)silyloxyheptanoic acid Chemical compound CC(C)[Si](C(C)C)(C(C)C)OC(CCC(O)=O)CCCC1=CC=CC=C1 DWMXFJUPTIHQGQ-UHFFFAOYSA-N 0.000 description 3
CISNDOAPFSYNNN-UHFFFAOYSA-N 7-phenyl-6-tri(propan-2-yl)silyloxyheptan-1-ol Chemical compound OCCCCCC(O[Si](C(C)C)(C(C)C)C(C)C)CC1=CC=CC=C1 CISNDOAPFSYNNN-UHFFFAOYSA-N 0.000 description 3
TXRHWAFMNZWLKU-UHFFFAOYSA-N 7-phenyl-6-tri(propan-2-yl)silyloxyheptanoic acid Chemical compound OC(=O)CCCCC(O[Si](C(C)C)(C(C)C)C(C)C)CC1=CC=CC=C1 TXRHWAFMNZWLKU-UHFFFAOYSA-N 0.000 description 3
NCWGFJOHLLPNNL-UHFFFAOYSA-N 7-pyridin-2-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCCCCCC1=CC=CC=N1 NCWGFJOHLLPNNL-UHFFFAOYSA-N 0.000 description 3
MLNUKPVTGKVHLU-UHFFFAOYSA-N 7-pyridin-3-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCCCCCC1=CC=CN=C1 MLNUKPVTGKVHLU-UHFFFAOYSA-N 0.000 description 3
WEMBCYPQIMGVNA-UHFFFAOYSA-N 7-pyridin-4-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCCCC#CC1=CC=NC=C1 WEMBCYPQIMGVNA-UHFFFAOYSA-N 0.000 description 3
RQAYKEVRCPFCHC-UHFFFAOYSA-N 7-thiophen-3-ylheptanoic acid Chemical compound OC(=O)CCCCCCC=1C=CSC=1 RQAYKEVRCPFCHC-UHFFFAOYSA-N 0.000 description 3
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
208000024827 Alzheimer disease Diseases 0.000 description 3
PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 3
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 3
108010010803 Gelatin Proteins 0.000 description 3
208000003577 HIV wasting syndrome Diseases 0.000 description 3
101001128911 Homo sapiens Neutral cholesterol ester hydrolase 1 Proteins 0.000 description 3
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
208000016285 Movement disease Diseases 0.000 description 3
206010028813 Nausea Diseases 0.000 description 3
102100032087 Neutral cholesterol ester hydrolase 1 Human genes 0.000 description 3
239000005642 Oleic acid Substances 0.000 description 3
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
208000018737 Parkinson disease Diseases 0.000 description 3
101150003085 Pdcl gene Proteins 0.000 description 3
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 3
RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
201000001880 Sexual dysfunction Diseases 0.000 description 3
208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 3
206010047700 Vomiting Diseases 0.000 description 3
230000002378 acidificating effect Effects 0.000 description 3
230000029936 alkylation Effects 0.000 description 3
238000005804 alkylation reaction Methods 0.000 description 3
125000000539 amino acid group Chemical group 0.000 description 3
150000001413 amino acids Chemical class 0.000 description 3
229910021529 ammonia Inorganic materials 0.000 description 3
230000000202 analgesic effect Effects 0.000 description 3
239000007864 aqueous solution Substances 0.000 description 3
150000001503 aryl iodides Chemical class 0.000 description 3
125000004429 atom Chemical group 0.000 description 3
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
230000000975 bioactive effect Effects 0.000 description 3
244000309464 bull Species 0.000 description 3
239000002775 capsule Substances 0.000 description 3
239000003054 catalyst Substances 0.000 description 3
229910052801 chlorine Inorganic materials 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
238000011161 development Methods 0.000 description 3
235000014113 dietary fatty acids Nutrition 0.000 description 3
238000010828 elution Methods 0.000 description 3
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
239000000284 extract Substances 0.000 description 3
239000000194 fatty acid Substances 0.000 description 3
229930195729 fatty acid Natural products 0.000 description 3
150000004665 fatty acids Chemical class 0.000 description 3
238000003818 flash chromatography Methods 0.000 description 3
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
239000008273 gelatin Substances 0.000 description 3
229920000159 gelatin Polymers 0.000 description 3
239000007903 gelatin capsule Substances 0.000 description 3
235000019322 gelatine Nutrition 0.000 description 3
235000011852 gelatine desserts Nutrition 0.000 description 3
230000014509 gene expression Effects 0.000 description 3
238000005984 hydrogenation reaction Methods 0.000 description 3
238000001802 infusion Methods 0.000 description 3
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
150000002576 ketones Chemical class 0.000 description 3
239000010410 layer Substances 0.000 description 3
XQABSPLPKDPISE-UHFFFAOYSA-N methyl 2-(4-phenylbutylsulfanyl)acetate Chemical compound COC(=O)CSCCCCC1=CC=CC=C1 XQABSPLPKDPISE-UHFFFAOYSA-N 0.000 description 3
OCKNDQDBYBWHSB-UHFFFAOYSA-N methyl 6-oxo-6-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexanoate Chemical compound O1C(C(=O)CCCCC(=O)OC)=NC=C1C1=CC=CC=N1 OCKNDQDBYBWHSB-UHFFFAOYSA-N 0.000 description 3
238000002156 mixing Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
125000002950 monocyclic group Chemical group 0.000 description 3
230000008693 nausea Effects 0.000 description 3
208000004296 neuralgia Diseases 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
229960002969 oleic acid Drugs 0.000 description 3
229910052760 oxygen Inorganic materials 0.000 description 3
239000001301 oxygen Substances 0.000 description 3
230000000144 pharmacologic effect Effects 0.000 description 3
229910052700 potassium Inorganic materials 0.000 description 3
IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 3
230000002441 reversible effect Effects 0.000 description 3
239000000932 sedative agent Substances 0.000 description 3
231100000872 sexual dysfunction Toxicity 0.000 description 3
KXCAEQNNTZANTK-UHFFFAOYSA-N stannane Chemical compound [SnH4] KXCAEQNNTZANTK-UHFFFAOYSA-N 0.000 description 3
229910000080 stannane Inorganic materials 0.000 description 3
229940032147 starch Drugs 0.000 description 3
239000008107 starch Substances 0.000 description 3
239000003826 tablet Substances 0.000 description 3
QCKAZROLJONPQH-UHFFFAOYSA-N tert-butyl 2-(4-phenylbutoxy)acetate Chemical compound CC(C)(C)OC(=O)COCCCCC1=CC=CC=C1 QCKAZROLJONPQH-UHFFFAOYSA-N 0.000 description 3
SESUPTFTFURERV-UHFFFAOYSA-N tert-butyl 6-phenylsulfanylhexanoate Chemical compound CC(C)(C)OC(=O)CCCCCSC1=CC=CC=C1 SESUPTFTFURERV-UHFFFAOYSA-N 0.000 description 3
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
GUENLYHQAHGHTF-UHFFFAOYSA-N tert-butyl n-[4-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-1-ynyl]phenyl]carbamate Chemical compound C1=CC(NC(=O)OC(C)(C)C)=CC=C1C#CCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 GUENLYHQAHGHTF-UHFFFAOYSA-N 0.000 description 3
RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
231100000331 toxic Toxicity 0.000 description 3
230000002588 toxic effect Effects 0.000 description 3
239000003981 vehicle Substances 0.000 description 3
230000008673 vomiting Effects 0.000 description 3
LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
ZPFMBPVMRCIDBP-UHFFFAOYSA-N 1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-[3-(trifluoromethyl)phenyl]heptan-1-one Chemical compound FC(F)(F)C1=CC=CC(CCCCCCC(=O)C=2OC(=CN=2)C=2N=CC=CC=2)=C1 ZPFMBPVMRCIDBP-UHFFFAOYSA-N 0.000 description 2
FBSDLZAMUQFBSX-UHFFFAOYSA-N 1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-[4-(trifluoromethyl)phenyl]heptan-1-one Chemical compound C1=CC(C(F)(F)F)=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 FBSDLZAMUQFBSX-UHFFFAOYSA-N 0.000 description 2
RLRWPRZGRQTJOO-UHFFFAOYSA-N 1-(5-pyridin-2-yl-1,3-oxazol-2-yl)prop-2-en-1-one Chemical compound O1C(C(=O)C=C)=NC=C1C1=CC=CC=N1 RLRWPRZGRQTJOO-UHFFFAOYSA-N 0.000 description 2
LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
JMLWXCJXOYDXRN-UHFFFAOYSA-N 1-chloro-3-iodobenzene Chemical compound ClC1=CC=CC(I)=C1 JMLWXCJXOYDXRN-UHFFFAOYSA-N 0.000 description 2
FPIRBHDGWMWJEP-UHFFFAOYSA-N 1-hydroxy-7-azabenzotriazole Chemical compound C1=CN=C2N(O)N=NC2=C1 FPIRBHDGWMWJEP-UHFFFAOYSA-N 0.000 description 2
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 2
ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
OLDVAUMUNFGMDQ-UHFFFAOYSA-N 2-chloro-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanol Chemical compound O1C(C(CCl)O)=NC=C1C1=CC=CC=N1 OLDVAUMUNFGMDQ-UHFFFAOYSA-N 0.000 description 2
IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
YYGNRTYZROVQPW-UHFFFAOYSA-N 2-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)C(O)CCCCCC1=CC=CC=C1 YYGNRTYZROVQPW-UHFFFAOYSA-N 0.000 description 2
WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
NHRHBUMFOMJBTE-UHFFFAOYSA-N 3-(3-phenylpropoxy)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCOCCCC1=CC=CC=C1 NHRHBUMFOMJBTE-UHFFFAOYSA-N 0.000 description 2
FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 2
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
ZJRFBTKSQDZBGP-UHFFFAOYSA-N 4-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 ZJRFBTKSQDZBGP-UHFFFAOYSA-N 0.000 description 2
XPBQQAHIVODAIC-UHFFFAOYSA-N 4-bromobutylbenzene Chemical compound BrCCCCC1=CC=CC=C1 XPBQQAHIVODAIC-UHFFFAOYSA-N 0.000 description 2
VFQRQRDNDMWSGP-UHFFFAOYSA-N 4-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCC(O)CCCC1=CC=CC=C1 VFQRQRDNDMWSGP-UHFFFAOYSA-N 0.000 description 2
229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
CJISYAZGALTYFL-UHFFFAOYSA-N 4-oxo-n-(2-phenylethyl)-4-(5-pyridin-2-yl-1,3-oxazol-2-yl)butanamide Chemical compound C=1C=CC=CC=1CCNC(=O)CCC(=O)C(O1)=NC=C1C1=CC=CC=N1 CJISYAZGALTYFL-UHFFFAOYSA-N 0.000 description 2
LDZLXQFDGRCELX-UHFFFAOYSA-N 4-phenylbutan-1-ol Chemical compound OCCCCC1=CC=CC=C1 LDZLXQFDGRCELX-UHFFFAOYSA-N 0.000 description 2
QTISZPXYPZNBQB-UHFFFAOYSA-N 4-phenylmethoxybutanal Chemical compound O=CCCCOCC1=CC=CC=C1 QTISZPXYPZNBQB-UHFFFAOYSA-N 0.000 description 2
YBEUSUFDLFUBLN-UHFFFAOYSA-N 5-benzylsulfinyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCCCS(=O)CC1=CC=CC=C1 YBEUSUFDLFUBLN-UHFFFAOYSA-N 0.000 description 2
IPHUIJQTUFWQFI-UHFFFAOYSA-N 5-benzylsulfonyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCCCS(=O)(=O)CC1=CC=CC=C1 IPHUIJQTUFWQFI-UHFFFAOYSA-N 0.000 description 2
GIUMSIUGRMSBQG-UHFFFAOYSA-N 5-bromo-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one Chemical compound O1C(C(=O)CCCCBr)=NC=C1C1=CC=CC=N1 GIUMSIUGRMSBQG-UHFFFAOYSA-N 0.000 description 2
GYMZRWOLXIOFJM-UHFFFAOYSA-N 5-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound C=1C=CC=CC=1CCC(O)CCCC(=O)C(O1)=NC=C1C1=CC=CC=N1 GYMZRWOLXIOFJM-UHFFFAOYSA-N 0.000 description 2
ORABKRHKEYNKES-UHFFFAOYSA-N 6-(n-methylanilino)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one Chemical compound C=1C=CC=CC=1N(C)CCCCCC(=O)C(O1)=NC=C1C1=CC=CC=N1 ORABKRHKEYNKES-UHFFFAOYSA-N 0.000 description 2
NVRVNSHHLPQGCU-UHFFFAOYSA-N 6-bromohexanoic acid Chemical compound OC(=O)CCCCCBr NVRVNSHHLPQGCU-UHFFFAOYSA-N 0.000 description 2
IJANKEVONHQJMK-UHFFFAOYSA-N 6-oxo-n-phenyl-6-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexanamide Chemical compound C=1C=CC=CC=1NC(=O)CCCCC(=O)C(O1)=NC=C1C1=CC=CC=N1 IJANKEVONHQJMK-UHFFFAOYSA-N 0.000 description 2
CAMPTKPQABGEIA-UHFFFAOYSA-N 6-phenoxy-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCCCCOC1=CC=CC=C1 CAMPTKPQABGEIA-UHFFFAOYSA-N 0.000 description 2
KJWBACOFHDCTDI-UHFFFAOYSA-N 6-phenoxyhexanoic acid Chemical compound OC(=O)CCCCCOC1=CC=CC=C1 KJWBACOFHDCTDI-UHFFFAOYSA-N 0.000 description 2
OKBHPVOFRDHZPQ-UHFFFAOYSA-N 6-phenylmethoxyhexanal Chemical compound O=CCCCCCOCC1=CC=CC=C1 OKBHPVOFRDHZPQ-UHFFFAOYSA-N 0.000 description 2
AITFDHBROVIWGR-UHFFFAOYSA-N 7-(2-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound FC1=CC=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 AITFDHBROVIWGR-UHFFFAOYSA-N 0.000 description 2
PIVGELBUZXOJRT-UHFFFAOYSA-N 7-(2-methoxyphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound COC1=CC=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 PIVGELBUZXOJRT-UHFFFAOYSA-N 0.000 description 2
XBJWLVYGLGRDLJ-UHFFFAOYSA-N 7-(2-methylsulfonylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound CS(=O)(=O)C1=CC=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 XBJWLVYGLGRDLJ-UHFFFAOYSA-N 0.000 description 2
STSOBNCCLHCLCI-UHFFFAOYSA-N 7-(3-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound FC1=CC=CC(CCCCCCC(=O)C=2OC(=CN=2)C=2N=CC=CC=2)=C1 STSOBNCCLHCLCI-UHFFFAOYSA-N 0.000 description 2
NWUNIVMFVYNPEW-UHFFFAOYSA-N 7-(3-methoxyphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound COC1=CC=CC(CCCCCCC(=O)C=2OC(=CN=2)C=2N=CC=CC=2)=C1 NWUNIVMFVYNPEW-UHFFFAOYSA-N 0.000 description 2
YZPFUMWLNJIYQL-UHFFFAOYSA-N 7-(3-methylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound CC1=CC=CC(CCCCCCC(=O)C=2OC(=CN=2)C=2N=CC=CC=2)=C1 YZPFUMWLNJIYQL-UHFFFAOYSA-N 0.000 description 2
SDGIPPVYUCFLJH-UHFFFAOYSA-N 7-(4-aminophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound C1=CC(N)=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 SDGIPPVYUCFLJH-UHFFFAOYSA-N 0.000 description 2
JFADYLNYNWJEAR-UHFFFAOYSA-N 7-(4-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound C1=CC(F)=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 JFADYLNYNWJEAR-UHFFFAOYSA-N 0.000 description 2
PMVVOJDCVSDECR-UHFFFAOYSA-N 7-(4-methylsulfonylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound C1=CC(S(=O)(=O)C)=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 PMVVOJDCVSDECR-UHFFFAOYSA-N 0.000 description 2
MCAHLKISWROEJU-UHFFFAOYSA-N 7-trimethylsilylhept-6-ynoic acid Chemical compound C[Si](C)(C)C#CCCCCC(O)=O MCAHLKISWROEJU-UHFFFAOYSA-N 0.000 description 2
108700023418 Amidases Proteins 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
102000018208 Cannabinoid Receptor Human genes 0.000 description 2
108050007331 Cannabinoid receptor Proteins 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 2
208000018652 Closed Head injury Diseases 0.000 description 2
102000010907 Cyclooxygenase 2 Human genes 0.000 description 2
108010037462 Cyclooxygenase 2 Proteins 0.000 description 2
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
201000004311 Gilles de la Tourette syndrome Diseases 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
208000023105 Huntington disease Diseases 0.000 description 2
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 2
208000014060 Niemann-Pick disease Diseases 0.000 description 2
208000003435 Optic Neuritis Diseases 0.000 description 2
BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
239000007868 Raney catalyst Substances 0.000 description 2
NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
229910000564 Raney nickel Inorganic materials 0.000 description 2
102000012479 Serine Proteases Human genes 0.000 description 2
108010022999 Serine Proteases Proteins 0.000 description 2
208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
235000021355 Stearic acid Nutrition 0.000 description 2
208000006011 Stroke Diseases 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
208000000323 Tourette Syndrome Diseases 0.000 description 2
208000016620 Tourette disease Diseases 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
229920004890 Triton X-100 Polymers 0.000 description 2
239000013504 Triton X-100 Substances 0.000 description 2
ZUSWDTWYONAOPH-UHFFFAOYSA-N [2-(trifluoromethyl)phenyl]hydrazine;hydrochloride Chemical group [Cl-].[NH3+]NC1=CC=CC=C1C(F)(F)F ZUSWDTWYONAOPH-UHFFFAOYSA-N 0.000 description 2
230000010933 acylation Effects 0.000 description 2
238000005917 acylation reaction Methods 0.000 description 2
125000004423 acyloxy group Chemical group 0.000 description 2
150000001298 alcohols Chemical class 0.000 description 2
125000005907 alkyl ester group Chemical group 0.000 description 2
VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 2
102000005922 amidase Human genes 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
230000000949 anxiolytic effect Effects 0.000 description 2
230000004596 appetite loss Effects 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
239000008135 aqueous vehicle Substances 0.000 description 2
239000012298 atmosphere Substances 0.000 description 2
201000004982 autoimmune uveitis Diseases 0.000 description 2
230000003542 behavioural effect Effects 0.000 description 2
HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
125000002619 bicyclic group Chemical group 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
239000008280 blood Substances 0.000 description 2
230000036760 body temperature Effects 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
239000006227 byproduct Substances 0.000 description 2
229910000019 calcium carbonate Inorganic materials 0.000 description 2
239000001506 calcium phosphate Substances 0.000 description 2
235000011010 calcium phosphates Nutrition 0.000 description 2
125000004432 carbon atom Chemical group C* 0.000 description 2
235000013985 cinnamic acid Nutrition 0.000 description 2
229930016911 cinnamic acid Natural products 0.000 description 2
239000003086 colorant Substances 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
238000001816 cooling Methods 0.000 description 2
230000008878 coupling Effects 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
239000013078 crystal Substances 0.000 description 2
125000000753 cycloalkyl group Chemical group 0.000 description 2
CZXHLRXAHDZQJF-UHFFFAOYSA-N cyclopentyl-(5-pyridin-2-yl-1,3-oxazol-2-yl)methanone Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)C1CCCC1 CZXHLRXAHDZQJF-UHFFFAOYSA-N 0.000 description 2
230000007423 decrease Effects 0.000 description 2
238000001212 derivatisation Methods 0.000 description 2
238000013461 design Methods 0.000 description 2
238000010586 diagram Methods 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
239000007884 disintegrant Substances 0.000 description 2
238000004821 distillation Methods 0.000 description 2
POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
238000012377 drug delivery Methods 0.000 description 2
125000006575 electron-withdrawing group Chemical group 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
238000001952 enzyme assay Methods 0.000 description 2
LTWOHZNXCOUWKH-UHFFFAOYSA-N ethyl 6-iodohexanoate Chemical compound CCOC(=O)CCCCCI LTWOHZNXCOUWKH-UHFFFAOYSA-N 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
239000000796 flavoring agent Substances 0.000 description 2
239000011737 fluorine Chemical group 0.000 description 2
235000019253 formic acid Nutrition 0.000 description 2
229960003692 gamma aminobutyric acid Drugs 0.000 description 2
210000001035 gastrointestinal tract Anatomy 0.000 description 2
229960004275 glycolic acid Drugs 0.000 description 2
229940093915 gynecological organic acid Drugs 0.000 description 2
MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
239000005556 hormone Substances 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
150000007529 inorganic bases Chemical class 0.000 description 2
206010022437 insomnia Diseases 0.000 description 2
208000001286 intracranial vasospasm Diseases 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
229910052740 iodine Inorganic materials 0.000 description 2
SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
229910052744 lithium Inorganic materials 0.000 description 2
230000006742 locomotor activity Effects 0.000 description 2
208000019017 loss of appetite Diseases 0.000 description 2
235000021266 loss of appetite Nutrition 0.000 description 2
239000000314 lubricant Substances 0.000 description 2
235000019359 magnesium stearate Nutrition 0.000 description 2
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
239000012528 membrane Substances 0.000 description 2
230000002503 metabolic effect Effects 0.000 description 2
NELYRIUOURRYFN-UHFFFAOYSA-N methyl 3-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-1-ynyl]benzoate Chemical compound COC(=O)C1=CC=CC(C#CCCCCC(=O)C=2OC(=CN=2)C=2N=CC=CC=2)=C1 NELYRIUOURRYFN-UHFFFAOYSA-N 0.000 description 2
QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
229920000609 methyl cellulose Polymers 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
239000001923 methylcellulose Substances 0.000 description 2
235000010981 methylcellulose Nutrition 0.000 description 2
150000007522 mineralic acids Chemical class 0.000 description 2
239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
BLBRWWCYYWNYBA-UHFFFAOYSA-N n-benzyl-5-oxo-5-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentanamide Chemical compound C=1C=CC=CC=1CNC(=O)CCCC(=O)C(O1)=NC=C1C1=CC=CC=N1 BLBRWWCYYWNYBA-UHFFFAOYSA-N 0.000 description 2
MLHBZVFOTDJTPK-UHFFFAOYSA-N n-methyl-3-phenylpropan-1-amine Chemical compound CNCCCC1=CC=CC=C1 MLHBZVFOTDJTPK-UHFFFAOYSA-N 0.000 description 2
208000015122 neurodegenerative disease Diseases 0.000 description 2
208000021722 neuropathic pain Diseases 0.000 description 2
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
150000007524 organic acids Chemical class 0.000 description 2
235000005985 organic acids Nutrition 0.000 description 2
150000007530 organic bases Chemical class 0.000 description 2
125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 2
150000002916 oxazoles Chemical class 0.000 description 2
ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 2
238000005897 peptide coupling reaction Methods 0.000 description 2
230000002093 peripheral effect Effects 0.000 description 2
239000001267 polyvinylpyrrolidone Substances 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
239000000843 powder Substances 0.000 description 2
239000002243 precursor Substances 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
230000009467 reduction Effects 0.000 description 2
238000006722 reduction reaction Methods 0.000 description 2
238000006268 reductive amination reaction Methods 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
230000006965 reversible inhibition Effects 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
150000003335 secondary amines Chemical class 0.000 description 2
230000001624 sedative effect Effects 0.000 description 2
238000002603 single-photon emission computed tomography Methods 0.000 description 2
239000000600 sorbitol Substances 0.000 description 2
235000010356 sorbitol Nutrition 0.000 description 2
239000008117 stearic acid Substances 0.000 description 2
229960004274 stearic acid Drugs 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
239000000829 suppository Substances 0.000 description 2
HJEZRYIJNHAIGY-UHFFFAOYSA-N tert-butyl 4-bromobutanoate Chemical compound CC(C)(C)OC(=O)CCCBr HJEZRYIJNHAIGY-UHFFFAOYSA-N 0.000 description 2
JOCPIDVCNQGZGA-UHFFFAOYSA-N tert-butyl 4-iodobutanoate Chemical compound CC(C)(C)OC(=O)CCCI JOCPIDVCNQGZGA-UHFFFAOYSA-N 0.000 description 2
MNNOXJIFTSBCFQ-UHFFFAOYSA-N tert-butyl 6-iodohexanoate Chemical compound CC(C)(C)OC(=O)CCCCCI MNNOXJIFTSBCFQ-UHFFFAOYSA-N 0.000 description 2
NYGACEWPQGVOEK-UHFFFAOYSA-N tert-butyl 6-phenoxyhexanoate Chemical compound CC(C)(C)OC(=O)CCCCCOC1=CC=CC=C1 NYGACEWPQGVOEK-UHFFFAOYSA-N 0.000 description 2
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
238000011200 topical administration Methods 0.000 description 2
LHJCZOXMCGQVDQ-UHFFFAOYSA-N tri(propan-2-yl)silyl trifluoromethanesulfonate Chemical compound CC(C)[Si](C(C)C)(C(C)C)OS(=O)(=O)C(F)(F)F LHJCZOXMCGQVDQ-UHFFFAOYSA-N 0.000 description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
239000011701 zinc Substances 0.000 description 2
OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
125000006582 (C5-C6) heterocycloalkyl group Chemical group 0.000 description 1
125000006705 (C5-C7) cycloalkyl group Chemical group 0.000 description 1
WXUAQHNMJWJLTG-VKHMYHEASA-N (S)-methylsuccinic acid Chemical compound OC(=O)[C@@H](C)CC(O)=O WXUAQHNMJWJLTG-VKHMYHEASA-N 0.000 description 1
UWYVPFMHMJIBHE-OWOJBTEDSA-N (e)-2-hydroxybut-2-enedioic acid Chemical compound OC(=O)\C=C(\O)C(O)=O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 1
UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
VGJKBWPZBVBXGI-UHFFFAOYSA-N 1,2-dichloro-3-iodobenzene Chemical compound ClC1=CC=CC(I)=C1Cl VGJKBWPZBVBXGI-UHFFFAOYSA-N 0.000 description 1
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
AICMHQCGMXRJIQ-UHFFFAOYSA-N 1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-[2-(trifluoromethyl)phenyl]heptan-1-one Chemical compound FC(F)(F)C1=CC=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 AICMHQCGMXRJIQ-UHFFFAOYSA-N 0.000 description 1
MPEOPBCQHNWNFB-UHFFFAOYSA-N 1-chloro-2-iodobenzene Chemical compound ClC1=CC=CC=C1I MPEOPBCQHNWNFB-UHFFFAOYSA-N 0.000 description 1
GWQSENYKCGJTRI-UHFFFAOYSA-N 1-chloro-4-iodobenzene Chemical compound ClC1=CC=C(I)C=C1 GWQSENYKCGJTRI-UHFFFAOYSA-N 0.000 description 1
LDMOEFOXLIZJOW-UHFFFAOYSA-N 1-dodecanesulfonic acid Chemical compound CCCCCCCCCCCCS(O)(=O)=O LDMOEFOXLIZJOW-UHFFFAOYSA-N 0.000 description 1
TYHUGKGZNOULKD-UHFFFAOYSA-N 1-fluoro-2-iodobenzene Chemical compound FC1=CC=CC=C1I TYHUGKGZNOULKD-UHFFFAOYSA-N 0.000 description 1
VSKSBSORLCDRHS-UHFFFAOYSA-N 1-fluoro-3-iodobenzene Chemical compound FC1=CC=CC(I)=C1 VSKSBSORLCDRHS-UHFFFAOYSA-N 0.000 description 1
KGNQDBQYEBMPFZ-UHFFFAOYSA-N 1-fluoro-4-iodobenzene Chemical compound FC1=CC=C(I)C=C1 KGNQDBQYEBMPFZ-UHFFFAOYSA-N 0.000 description 1
IGZGUYVVBABKOY-UHFFFAOYSA-N 1-iodo-2-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1I IGZGUYVVBABKOY-UHFFFAOYSA-N 0.000 description 1
JXMZUNPWVXQADG-UHFFFAOYSA-N 1-iodo-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1I JXMZUNPWVXQADG-UHFFFAOYSA-N 0.000 description 1
IGISPMBUGPHLBY-UHFFFAOYSA-N 1-iodo-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC(I)=C1 IGISPMBUGPHLBY-UHFFFAOYSA-N 0.000 description 1
CBYAZOKPJYBCHE-UHFFFAOYSA-N 1-iodo-3-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC(I)=C1 CBYAZOKPJYBCHE-UHFFFAOYSA-N 0.000 description 1
SKGRFPGOGCHDPC-UHFFFAOYSA-N 1-iodo-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(I)C=C1 SKGRFPGOGCHDPC-UHFFFAOYSA-N 0.000 description 1
SCCCFNJTCDSLCY-UHFFFAOYSA-N 1-iodo-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(I)C=C1 SCCCFNJTCDSLCY-UHFFFAOYSA-N 0.000 description 1
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
SQAINHDHICKHLX-UHFFFAOYSA-N 1-naphthaldehyde Chemical compound C1=CC=C2C(C=O)=CC=CC2=C1 SQAINHDHICKHLX-UHFFFAOYSA-N 0.000 description 1
LNETULKMXZVUST-UHFFFAOYSA-N 1-naphthoic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=CC2=C1 LNETULKMXZVUST-UHFFFAOYSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
HCSBTDBGTNZOAB-UHFFFAOYSA-N 2,3-dinitrobenzoic acid Chemical compound OC(=O)C1=CC=CC([N+]([O-])=O)=C1[N+]([O-])=O HCSBTDBGTNZOAB-UHFFFAOYSA-N 0.000 description 1
PKZJLOCLABXVMC-UHFFFAOYSA-N 2-Methoxybenzaldehyde Chemical compound COC1=CC=CC=C1C=O PKZJLOCLABXVMC-UHFFFAOYSA-N 0.000 description 1
DTLJRCZJLMKFGO-UHFFFAOYSA-N 2-[methyl(4-phenylbutyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanol Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(O)CN(C)CCCCC1=CC=CC=C1 DTLJRCZJLMKFGO-UHFFFAOYSA-N 0.000 description 1
125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
CSDSSGBPEUDDEE-UHFFFAOYSA-N 2-formylpyridine Chemical compound O=CC1=CC=CC=N1 CSDSSGBPEUDDEE-UHFFFAOYSA-N 0.000 description 1
CCZWSTFVHJPCEM-UHFFFAOYSA-N 2-iodopyridine Chemical compound IC1=CC=CC=N1 CCZWSTFVHJPCEM-UHFFFAOYSA-N 0.000 description 1
CTUPBAXICGISQP-UHFFFAOYSA-N 2-methylthiobenzaldehyde Chemical compound CC1=CC=CC=C1C=S CTUPBAXICGISQP-UHFFFAOYSA-N 0.000 description 1
PJKVFARRVXDXAD-UHFFFAOYSA-N 2-naphthaldehyde Chemical compound C1=CC=CC2=CC(C=O)=CC=C21 PJKVFARRVXDXAD-UHFFFAOYSA-N 0.000 description 1
125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
HNZHNVCIFJWEMA-UHFFFAOYSA-N 3-(3-phenylpropoxy)propanoic acid Chemical compound OC(=O)CCOCCCC1=CC=CC=C1 HNZHNVCIFJWEMA-UHFFFAOYSA-N 0.000 description 1
BRMWTNUJHUMWMS-UHFFFAOYSA-N 3-Methylhistidine Natural products CN1C=NC(CC(N)C(O)=O)=C1 BRMWTNUJHUMWMS-UHFFFAOYSA-N 0.000 description 1
IHBVNSPHKMCPST-UHFFFAOYSA-N 3-bromopropanoyl chloride Chemical compound ClC(=O)CCBr IHBVNSPHKMCPST-UHFFFAOYSA-N 0.000 description 1
HGZJJKZPPMFIBU-UHFFFAOYSA-N 3-formylbenzonitrile Chemical compound O=CC1=CC=CC(C#N)=C1 HGZJJKZPPMFIBU-UHFFFAOYSA-N 0.000 description 1
RBIGKSZIQCTIJF-UHFFFAOYSA-N 3-formylthiophene Chemical compound O=CC=1C=CSC=1 RBIGKSZIQCTIJF-UHFFFAOYSA-N 0.000 description 1
XDELKSRGBLWMBA-UHFFFAOYSA-N 3-iodopyridine Chemical compound IC1=CC=CN=C1 XDELKSRGBLWMBA-UHFFFAOYSA-N 0.000 description 1
WMPDAIZRQDCGFH-UHFFFAOYSA-N 3-methoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1 WMPDAIZRQDCGFH-UHFFFAOYSA-N 0.000 description 1
DNRIBXNMXFBONF-UHFFFAOYSA-N 3-methylthiobenzaldehyde Chemical compound CC1=CC=CC(C=S)=C1 DNRIBXNMXFBONF-UHFFFAOYSA-N 0.000 description 1
XYVMOLOUBJBNBF-UHFFFAOYSA-N 3h-1,3-oxazol-2-one Chemical class OC1=NC=CO1 XYVMOLOUBJBNBF-UHFFFAOYSA-N 0.000 description 1
ZUQOBHTUMCEQBG-UHFFFAOYSA-N 4-amino-5-hydroxynaphthalene-1,7-disulfonic acid Chemical compound OS(=O)(=O)C1=CC(O)=C2C(N)=CC=C(S(O)(=O)=O)C2=C1 ZUQOBHTUMCEQBG-UHFFFAOYSA-N 0.000 description 1
GRHQDJDRGZFIPO-UHFFFAOYSA-N 4-bromobutanoic acid Chemical compound OC(=O)CCCBr GRHQDJDRGZFIPO-UHFFFAOYSA-N 0.000 description 1
LRTRXDSAJLSRTG-UHFFFAOYSA-N 4-bromobutanoyl chloride Chemical compound ClC(=O)CCCBr LRTRXDSAJLSRTG-UHFFFAOYSA-N 0.000 description 1
WZWIQYMTQZCSKI-UHFFFAOYSA-N 4-cyanobenzaldehyde Chemical compound O=CC1=CC=C(C#N)C=C1 WZWIQYMTQZCSKI-UHFFFAOYSA-N 0.000 description 1
125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 description 1
RTLUPHDWSUGAOS-UHFFFAOYSA-N 4-iodopyridine Chemical compound IC1=CC=NC=C1 RTLUPHDWSUGAOS-UHFFFAOYSA-N 0.000 description 1
PIMQQGJMDMAZGT-UHFFFAOYSA-N 4-methylthiobenzaldehyde Chemical compound CC1=CC=C(C=S)C=C1 PIMQQGJMDMAZGT-UHFFFAOYSA-N 0.000 description 1
YKYVPFIBWVQZCE-UHFFFAOYSA-N 4-phenoxybutanoic acid Chemical compound OC(=O)CCCOC1=CC=CC=C1 YKYVPFIBWVQZCE-UHFFFAOYSA-N 0.000 description 1
TYROJDFHUXSBHC-UHFFFAOYSA-N 4-phenylmethoxybutan-1-ol Chemical compound OCCCCOCC1=CC=CC=C1 TYROJDFHUXSBHC-UHFFFAOYSA-N 0.000 description 1
SRSGVKWWVXWSJT-ATVHPVEESA-N 5-[(z)-(5-fluoro-2-oxo-1h-indol-3-ylidene)methyl]-2,4-dimethyl-n-(2-pyrrolidin-1-ylethyl)-1h-pyrrole-3-carboxamide Chemical compound CC=1NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C(C)C=1C(=O)NCCN1CCCC1 SRSGVKWWVXWSJT-ATVHPVEESA-N 0.000 description 1
WNXNUPJZWYOKMW-UHFFFAOYSA-N 5-bromopentanoic acid Chemical compound OC(=O)CCCCBr WNXNUPJZWYOKMW-UHFFFAOYSA-N 0.000 description 1
OKRUMSWHDWKGHA-UHFFFAOYSA-N 5-bromopentanoyl chloride Chemical compound ClC(=O)CCCCBr OKRUMSWHDWKGHA-UHFFFAOYSA-N 0.000 description 1
GPERFEGHZZLCRG-UHFFFAOYSA-N 5-methoxy-4-methyl-5-oxopentanoic acid Chemical compound COC(=O)C(C)CCC(O)=O GPERFEGHZZLCRG-UHFFFAOYSA-N 0.000 description 1
YYMQHFDGNJKEDZ-UHFFFAOYSA-N 5-phenylmethoxy-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CCCCOCC1=CC=CC=C1 YYMQHFDGNJKEDZ-UHFFFAOYSA-N 0.000 description 1
RZVDPWSEPVHOPU-UHFFFAOYSA-N 5-phenylmethoxypentan-1-ol Chemical compound OCCCCCOCC1=CC=CC=C1 RZVDPWSEPVHOPU-UHFFFAOYSA-N 0.000 description 1
MXXWSDBAURXMNQ-UHFFFAOYSA-N 5-phenylmethoxypentanoic acid Chemical compound OC(=O)CCCCOCC1=CC=CC=C1 MXXWSDBAURXMNQ-UHFFFAOYSA-N 0.000 description 1
FINOPSACFXSAKB-UHFFFAOYSA-N 5-phenylpentanal Chemical compound O=CCCCCC1=CC=CC=C1 FINOPSACFXSAKB-UHFFFAOYSA-N 0.000 description 1
HBPVGJGBRWIVSX-UHFFFAOYSA-N 6-bromohexanoyl chloride Chemical compound ClC(=O)CCCCCBr HBPVGJGBRWIVSX-UHFFFAOYSA-N 0.000 description 1
DWEOFYCDORNSEJ-UHFFFAOYSA-N 6-methoxy-5-methyl-6-oxohexanoic acid Chemical compound COC(=O)C(C)CCCC(O)=O DWEOFYCDORNSEJ-UHFFFAOYSA-N 0.000 description 1
FMSYZEGXVQMCSX-UHFFFAOYSA-N 6-phenylmethoxyhexan-1-ol Chemical compound OCCCCCCOCC1=CC=CC=C1 FMSYZEGXVQMCSX-UHFFFAOYSA-N 0.000 description 1
JBBDNZYASTVJES-UHFFFAOYSA-N 7-(2-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one Chemical compound ClC1=CC=CC=C1C#CCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 JBBDNZYASTVJES-UHFFFAOYSA-N 0.000 description 1
RGBFZMIPBWNGPE-UHFFFAOYSA-N 7-(2-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound ClC1=CC=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 RGBFZMIPBWNGPE-UHFFFAOYSA-N 0.000 description 1
UFIXUGYHLZCFPI-UHFFFAOYSA-N 7-(2-methylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound CC1=CC=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 UFIXUGYHLZCFPI-UHFFFAOYSA-N 0.000 description 1
RUDYVULGBMMUDG-UHFFFAOYSA-N 7-(3-aminophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound NC1=CC=CC(CCCCCCC(=O)C=2OC(=CN=2)C=2N=CC=CC=2)=C1 RUDYVULGBMMUDG-UHFFFAOYSA-N 0.000 description 1
DCNZTWQVUGZHKE-UHFFFAOYSA-N 7-(4-methoxyphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound C1=CC(OC)=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 DCNZTWQVUGZHKE-UHFFFAOYSA-N 0.000 description 1
PQAKXMUPSKPASV-UHFFFAOYSA-N 7-(4-methylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound C1=CC(C)=CC=C1CCCCCCC(=O)C1=NC=C(C=2N=CC=CC=2)O1 PQAKXMUPSKPASV-UHFFFAOYSA-N 0.000 description 1
GTNCYKSWIJTPPW-UHFFFAOYSA-N 7-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one Chemical compound C=1C=CC=CC=1C(O)CCCCCC(=O)C(O1)=NC=C1C1=CC=CC=N1 GTNCYKSWIJTPPW-UHFFFAOYSA-N 0.000 description 1
NJVXRGCJANZJJK-UHFFFAOYSA-N 7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptane-1,3-dione Chemical compound N=1C=C(C=2N=CC=CC=2)OC=1C(=O)CC(=O)CCCCC1=CC=CC=C1 NJVXRGCJANZJJK-UHFFFAOYSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
208000030507 AIDS Diseases 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
235000019489 Almond oil Nutrition 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
244000144725 Amygdalus communis Species 0.000 description 1
241001535291 Analges Species 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
208000008035 Back Pain Diseases 0.000 description 1
239000005711 Benzoic acid Substances 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
206010069632 Bladder dysfunction Diseases 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
229940124638 COX inhibitor Drugs 0.000 description 1
206010006895 Cachexia Diseases 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
206010058019 Cancer Pain Diseases 0.000 description 1
WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
206010064012 Central pain syndrome Diseases 0.000 description 1
108090000751 Ceramidases Proteins 0.000 description 1
102000004201 Ceramidases Human genes 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
206010010144 Completed suicide Diseases 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
206010012335 Dependence Diseases 0.000 description 1
YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
208000012661 Dyskinesia Diseases 0.000 description 1
208000005171 Dysmenorrhea Diseases 0.000 description 1
101710134987 Esterase 6 Proteins 0.000 description 1
BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
208000010412 Glaucoma Diseases 0.000 description 1
208000032612 Glial tumor Diseases 0.000 description 1
206010018338 Glioma Diseases 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
239000007818 Grignard reagent Substances 0.000 description 1
239000007821 HATU Substances 0.000 description 1
208000031886 HIV Infections Diseases 0.000 description 1
208000037357 HIV infectious disease Diseases 0.000 description 1
206010019233 Headaches Diseases 0.000 description 1
101000838579 Homo sapiens Serine/threonine-protein kinase TAO1 Proteins 0.000 description 1
239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
241000257303 Hymenoptera Species 0.000 description 1
208000004454 Hyperalgesia Diseases 0.000 description 1
208000035154 Hyperesthesia Diseases 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
206010021333 Ileus paralytic Diseases 0.000 description 1
206010062016 Immunosuppression Diseases 0.000 description 1
208000022559 Inflammatory bowel disease Diseases 0.000 description 1
201000005081 Intestinal Pseudo-Obstruction Diseases 0.000 description 1
SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
UCUNFLYVYCGDHP-BYPYZUCNSA-N L-methionine sulfone Chemical compound CS(=O)(=O)CC[C@H](N)C(O)=O UCUNFLYVYCGDHP-BYPYZUCNSA-N 0.000 description 1
SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
239000005639 Lauric acid Substances 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
208000008930 Low Back Pain Diseases 0.000 description 1
241000023320 Luma <angiosperm> Species 0.000 description 1
102100037611 Lysophospholipase Human genes 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
238000006845 Michael addition reaction Methods 0.000 description 1
229920000168 Microcrystalline cellulose Polymers 0.000 description 1
208000019695 Migraine disease Diseases 0.000 description 1
101100189356 Mus musculus Papolb gene Proteins 0.000 description 1
208000008238 Muscle Spasticity Diseases 0.000 description 1
206010028391 Musculoskeletal Pain Diseases 0.000 description 1
JDHILDINMRGULE-LURJTMIESA-N N(pros)-methyl-L-histidine Chemical compound CN1C=NC=C1C[C@H](N)C(O)=O JDHILDINMRGULE-LURJTMIESA-N 0.000 description 1
FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical class CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 1
0 NC=C(c1ncccc1)O*C(CCCCCOc1ccccc1)=O Chemical compound NC=C(c1ncccc1)O*C(CCCCCOc1ccccc1)=O 0.000 description 1
CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
206010028817 Nausea and vomiting symptoms Diseases 0.000 description 1
RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
206010028836 Neck pain Diseases 0.000 description 1
208000036110 Neuroinflammatory disease Diseases 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 description 1
235000021314 Palmitic acid Nutrition 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
IGVPBCZDHMIOJH-UHFFFAOYSA-N Phenyl butyrate Chemical class CCCC(=O)OC1=CC=CC=C1 IGVPBCZDHMIOJH-UHFFFAOYSA-N 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
108010058864 Phospholipases A2 Proteins 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
208000004550 Postoperative Pain Diseases 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
239000004365 Protease Substances 0.000 description 1
208000003251 Pruritus Diseases 0.000 description 1
IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
208000034189 Sclerosis Diseases 0.000 description 1
229940124639 Selective inhibitor Drugs 0.000 description 1
OZPDGESCTGGNAD-CIUDSAMLSA-N Ser-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CO OZPDGESCTGGNAD-CIUDSAMLSA-N 0.000 description 1
102100028948 Serine/threonine-protein kinase TAO1 Human genes 0.000 description 1
208000010340 Sleep Deprivation Diseases 0.000 description 1
238000003477 Sonogashira cross-coupling reaction Methods 0.000 description 1
208000007107 Stomach Ulcer Diseases 0.000 description 1
208000013200 Stress disease Diseases 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
208000008548 Tension-Type Headache Diseases 0.000 description 1
208000030886 Traumatic Brain injury Diseases 0.000 description 1
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
ZZXDRXVIRVJQBT-UHFFFAOYSA-M Xylenesulfonate Chemical compound CC1=CC=CC(S([O-])(=O)=O)=C1C ZZXDRXVIRVJQBT-UHFFFAOYSA-M 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
JHUYNQGHNWXETM-UHFFFAOYSA-M [Br-].[Mg+]CCCC1=CC=CC=C1 Chemical compound [Br-].[Mg+]CCCC1=CC=CC=C1 JHUYNQGHNWXETM-UHFFFAOYSA-M 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
229960000583 acetic acid Drugs 0.000 description 1
150000001242 acetic acid derivatives Chemical class 0.000 description 1
IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
239000012346 acetyl chloride Substances 0.000 description 1
YTIVTFGABIZHHX-UHFFFAOYSA-L acetylenedicarboxylate(2-) Chemical compound [O-]C(=O)C#CC([O-])=O YTIVTFGABIZHHX-UHFFFAOYSA-L 0.000 description 1
239000012190 activator Substances 0.000 description 1
IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
150000001335 aliphatic alkanes Chemical class 0.000 description 1
150000008044 alkali metal hydroxides Chemical class 0.000 description 1
229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
150000003973 alkyl amines Chemical class 0.000 description 1
150000001350 alkyl halides Chemical class 0.000 description 1
125000000304 alkynyl group Chemical group 0.000 description 1
208000028004 allergic respiratory disease Diseases 0.000 description 1
239000008168 almond oil Substances 0.000 description 1
229940061720 alpha hydroxy acid Drugs 0.000 description 1
150000001280 alpha hydroxy acids Chemical class 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
229940063655 aluminum stearate Drugs 0.000 description 1
230000003444 anaesthetic effect Effects 0.000 description 1
208000022531 anorexia Diseases 0.000 description 1
208000004793 anterograde amnesia Diseases 0.000 description 1
125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
239000002948 appetite stimulant Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
230000003796 beauty Effects 0.000 description 1
230000006399 behavior Effects 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
UENWRTRMUIOCKN-UHFFFAOYSA-N benzyl thiol Chemical compound SCC1=CC=CC=C1 UENWRTRMUIOCKN-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
229940000635 beta-alanine Drugs 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
239000012867 bioactive agent Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
230000008499 blood brain barrier function Effects 0.000 description 1
210000001218 blood-brain barrier Anatomy 0.000 description 1
230000037396 body weight Effects 0.000 description 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
239000004327 boric acid Substances 0.000 description 1
208000029028 brain injury Diseases 0.000 description 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
239000000872 buffer Substances 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
FGNLEIGUMSBZQP-UHFFFAOYSA-N cadaverine dihydrochloride Chemical compound Cl.Cl.NCCCCCN FGNLEIGUMSBZQP-UHFFFAOYSA-N 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
235000010216 calcium carbonate Nutrition 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
229940065144 cannabinoids Drugs 0.000 description 1
150000004657 carbamic acid derivatives Chemical class 0.000 description 1
150000001721 carbon Chemical group 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
MMCOUVMKNAHQOY-UHFFFAOYSA-N carbonoperoxoic acid Chemical class OOC(O)=O MMCOUVMKNAHQOY-UHFFFAOYSA-N 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
125000002843 carboxylic acid group Chemical group 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
230000001925 catabolic effect Effects 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
235000010980 cellulose Nutrition 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
210000001175 cerebrospinal fluid Anatomy 0.000 description 1
230000008859 change Effects 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
KVSASDOGYIBWTA-UHFFFAOYSA-N chloro benzoate Chemical compound ClOC(=O)C1=CC=CC=C1 KVSASDOGYIBWTA-UHFFFAOYSA-N 0.000 description 1
IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
229960002173 citrulline Drugs 0.000 description 1
235000013477 citrulline Nutrition 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
239000010941 cobalt Substances 0.000 description 1
229910017052 cobalt Inorganic materials 0.000 description 1
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
239000003240 coconut oil Substances 0.000 description 1
235000019864 coconut oil Nutrition 0.000 description 1
238000004891 communication Methods 0.000 description 1
230000006957 competitive inhibition Effects 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
239000003433 contraceptive agent Substances 0.000 description 1
230000002254 contraceptive effect Effects 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
206010061428 decreased appetite Diseases 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
239000012649 demethylating agent Substances 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
239000012351 deprotecting agent Substances 0.000 description 1
238000010511 deprotection reaction Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
229910052805 deuterium Inorganic materials 0.000 description 1
BIPUHAHGLJKIPK-UHFFFAOYSA-N dicyclopropylmethanone Chemical compound C1CC1C(=O)C1CC1 BIPUHAHGLJKIPK-UHFFFAOYSA-N 0.000 description 1
150000001993 dienes Chemical class 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
235000011180 diphosphates Nutrition 0.000 description 1
WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000009826 distribution Methods 0.000 description 1
PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
239000008298 dragée Substances 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
239000006274 endogenous ligand Substances 0.000 description 1
238000005837 enolization reaction Methods 0.000 description 1
239000002702 enteric coating Substances 0.000 description 1
238000009505 enteric coating Methods 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
125000001033 ether group Chemical group 0.000 description 1
DXBULVYHTICWKT-UHFFFAOYSA-N ethyl 6-bromohexanoate Chemical compound CCOC(=O)CCCCCBr DXBULVYHTICWKT-UHFFFAOYSA-N 0.000 description 1
UKFXDFUAPNAMPJ-UHFFFAOYSA-N ethylmalonic acid Chemical compound CCC(C(O)=O)C(O)=O UKFXDFUAPNAMPJ-UHFFFAOYSA-N 0.000 description 1
238000000605 extraction Methods 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000000945 filler Substances 0.000 description 1
239000012065 filter cake Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
IENNDZOEXGZWGX-DOFZRALJSA-N fluoro-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoxy]phosphinic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCOP(O)(F)=O IENNDZOEXGZWGX-DOFZRALJSA-N 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
CNUDBTRUORMMPA-UHFFFAOYSA-N formylthiophene Chemical compound O=CC1=CC=CS1 CNUDBTRUORMMPA-UHFFFAOYSA-N 0.000 description 1
239000012458 free base Substances 0.000 description 1
229940050411 fumarate Drugs 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
229960002598 fumaric acid Drugs 0.000 description 1
230000006870 function Effects 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
210000003976 gap junction Anatomy 0.000 description 1
201000005917 gastric ulcer Diseases 0.000 description 1
208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
239000000499 gel Substances 0.000 description 1
230000002518 glial effect Effects 0.000 description 1
239000008103 glucose Substances 0.000 description 1
235000001727 glucose Nutrition 0.000 description 1
229940097043 glucuronic acid Drugs 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
229940074045 glyceryl distearate Drugs 0.000 description 1
229940075507 glyceryl monostearate Drugs 0.000 description 1
239000008187 granular material Substances 0.000 description 1
150000004795 grignard reagents Chemical class 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
150000002367 halogens Chemical class 0.000 description 1
231100000869 headache Toxicity 0.000 description 1
230000036541 health Effects 0.000 description 1
230000023597 hemostasis Effects 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
125000000623 heterocyclic group Chemical group 0.000 description 1
KKLGDUSGQMHBPB-UHFFFAOYSA-N hex-2-ynedioic acid Chemical compound OC(=O)CCC#CC(O)=O KKLGDUSGQMHBPB-UHFFFAOYSA-N 0.000 description 1
VBZWSGALLODQNC-UHFFFAOYSA-N hexafluoroacetone Chemical compound FC(F)(F)C(=O)C(F)(F)F VBZWSGALLODQNC-UHFFFAOYSA-N 0.000 description 1
VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
150000004677 hydrates Chemical class 0.000 description 1
150000002431 hydrogen Chemical class 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910000042 hydrogen bromide Inorganic materials 0.000 description 1
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
238000005805 hydroxylation reaction Methods 0.000 description 1
229960002591 hydroxyproline Drugs 0.000 description 1
230000000147 hypnotic effect Effects 0.000 description 1
229960001680 ibuprofen Drugs 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
230000001506 immunosuppresive effect Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
239000003701 inert diluent Substances 0.000 description 1
239000007972 injectable composition Substances 0.000 description 1
208000014674 injury Diseases 0.000 description 1
239000013067 intermediate product Substances 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
239000011630 iodine Chemical group 0.000 description 1
125000002346 iodo group Chemical group I* 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
230000002427 irreversible effect Effects 0.000 description 1
208000002551 irritable bowel syndrome Diseases 0.000 description 1
230000007794 irritation Effects 0.000 description 1
229940045996 isethionic acid Drugs 0.000 description 1
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
RGXCTRIQQODGIZ-UHFFFAOYSA-O isodesmosine Chemical compound OC(=O)C(N)CCCC[N+]1=CC(CCC(N)C(O)=O)=CC(CCC(N)C(O)=O)=C1CCCC(N)C(O)=O RGXCTRIQQODGIZ-UHFFFAOYSA-O 0.000 description 1
125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
238000011813 knockout mouse model Methods 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
229960000448 lactic acid Drugs 0.000 description 1
239000008101 lactose Substances 0.000 description 1
229940033355 lauric acid Drugs 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
229960004502 levodopa Drugs 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
239000012669 liquid formulation Substances 0.000 description 1
229940057995 liquid paraffin Drugs 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
239000006166 lysate Substances 0.000 description 1
OVWYEQOVUDKZNU-UHFFFAOYSA-N m-tolualdehyde Chemical compound CC1=CC=CC(C=O)=C1 OVWYEQOVUDKZNU-UHFFFAOYSA-N 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
SCEZYJKGDJPHQO-UHFFFAOYSA-M magnesium;methanidylbenzene;chloride Chemical compound [Mg+2].[Cl-].[CH2-]C1=CC=CC=C1 SCEZYJKGDJPHQO-UHFFFAOYSA-M 0.000 description 1
238000011418 maintenance treatment Methods 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
229940098895 maleic acid Drugs 0.000 description 1
210000005171 mammalian brain Anatomy 0.000 description 1
229960002510 mandelic acid Drugs 0.000 description 1
WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
239000000463 material Substances 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
125000005341 metaphosphate group Chemical group 0.000 description 1
229940098779 methanesulfonic acid Drugs 0.000 description 1
BXXLTVBTDZXPTN-UHFFFAOYSA-N methyl 2-iodobenzoate Chemical compound COC(=O)C1=CC=CC=C1I BXXLTVBTDZXPTN-UHFFFAOYSA-N 0.000 description 1
MKIJJIMOAABWGF-UHFFFAOYSA-N methyl 2-sulfanylacetate Chemical compound COC(=O)CS MKIJJIMOAABWGF-UHFFFAOYSA-N 0.000 description 1
NPXOIGSBRLCOSD-UHFFFAOYSA-N methyl 3-iodobenzoate Chemical compound COC(=O)C1=CC=CC(I)=C1 NPXOIGSBRLCOSD-UHFFFAOYSA-N 0.000 description 1
ZYCFMHCDZSVIGF-UHFFFAOYSA-N methyl 4-amino-1-(2-aminoethyl)-2-butylimidazo[4,5-c]quinoline-7-carboxylate Chemical compound NC1=NC=2C=C(C=CC=2C2=C1N=C(N2CCN)CCCC)C(=O)OC ZYCFMHCDZSVIGF-UHFFFAOYSA-N 0.000 description 1
DYUWQWMXZHDZOR-UHFFFAOYSA-N methyl 4-iodobenzoate Chemical compound COC(=O)C1=CC=C(I)C=C1 DYUWQWMXZHDZOR-UHFFFAOYSA-N 0.000 description 1
IZYBEMGNIUSSAX-UHFFFAOYSA-N methyl benzenecarboperoxoate Chemical compound COOC(=O)C1=CC=CC=C1 IZYBEMGNIUSSAX-UHFFFAOYSA-N 0.000 description 1
229940095102 methyl benzoate Drugs 0.000 description 1
150000005217 methyl ethers Chemical class 0.000 description 1
OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
235000019813 microcrystalline cellulose Nutrition 0.000 description 1
239000008108 microcrystalline cellulose Substances 0.000 description 1
229940016286 microcrystalline cellulose Drugs 0.000 description 1
206010027599 migraine Diseases 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
239000012452 mother liquor Substances 0.000 description 1
LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
125000001624 naphthyl group Chemical group 0.000 description 1
CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
229960002009 naproxen Drugs 0.000 description 1
230000003959 neuroinflammation Effects 0.000 description 1
230000003227 neuromodulating effect Effects 0.000 description 1
230000004112 neuroprotection Effects 0.000 description 1
230000000324 neuroprotective effect Effects 0.000 description 1
229960002715 nicotine Drugs 0.000 description 1
SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
230000003040 nociceptive effect Effects 0.000 description 1
230000000269 nucleophilic effect Effects 0.000 description 1
BTFQKIATRPGRBS-UHFFFAOYSA-N o-tolualdehyde Chemical compound CC1=CC=CC=C1C=O BTFQKIATRPGRBS-UHFFFAOYSA-N 0.000 description 1
XYVHUTVZCCRZPW-UHFFFAOYSA-N octan-2-yl 4-bromo-3-oxobutanoate Chemical compound CCCCCCC(C)OC(=O)CC(=O)CBr XYVHUTVZCCRZPW-UHFFFAOYSA-N 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
229940127240 opiate Drugs 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
239000008008 oral excipient Substances 0.000 description 1
239000007935 oral tablet Substances 0.000 description 1
229960003104 ornithine Drugs 0.000 description 1
229940116315 oxalic acid Drugs 0.000 description 1
235000006408 oxalic acid Nutrition 0.000 description 1
239000007800 oxidant agent Substances 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
FXLOVSHXALFLKQ-UHFFFAOYSA-N p-tolualdehyde Chemical compound CC1=CC=C(C=O)C=C1 FXLOVSHXALFLKQ-UHFFFAOYSA-N 0.000 description 1
229940098695 palmitic acid Drugs 0.000 description 1
QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
201000007620 paralytic ileus Diseases 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
229940124531 pharmaceutical excipient Drugs 0.000 description 1
239000002831 pharmacologic agent Substances 0.000 description 1
125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
229940117803 phenethylamine Drugs 0.000 description 1
DYUMLJSJISTVPV-UHFFFAOYSA-N phenyl propanoate Chemical compound CCC(=O)OC1=CC=CC=C1 DYUMLJSJISTVPV-UHFFFAOYSA-N 0.000 description 1
229940049953 phenylacetate Drugs 0.000 description 1
WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
125000005541 phosphonamide group Chemical group 0.000 description 1
150000003014 phosphoric acid esters Chemical class 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
125000003367 polycyclic group Chemical group 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229940068918 polyethylene glycol 400 Drugs 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
208000028173 post-traumatic stress disease Diseases 0.000 description 1
230000001242 postsynaptic effect Effects 0.000 description 1
239000011591 potassium Substances 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
238000012746 preparative thin layer chromatography Methods 0.000 description 1
230000003518 presynaptic effect Effects 0.000 description 1
230000002265 prevention Effects 0.000 description 1
150000003141 primary amines Chemical class 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
230000007425 progressive decline Effects 0.000 description 1
KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
229940095574 propionic acid Drugs 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
UORVCLMRJXCDCP-UHFFFAOYSA-M propynoate Chemical compound [O-]C(=O)C#C UORVCLMRJXCDCP-UHFFFAOYSA-M 0.000 description 1
230000004224 protection Effects 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
229940107700 pyruvic acid Drugs 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000001959 radiotherapy Methods 0.000 description 1
239000011535 reaction buffer Substances 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
230000007017 scission Effects 0.000 description 1
229940116351 sebacate Drugs 0.000 description 1
CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 description 1
125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
201000009881 secretory diarrhea Diseases 0.000 description 1
229940125723 sedative agent Drugs 0.000 description 1
125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
230000000862 serotonergic effect Effects 0.000 description 1
150000004666 short chain fatty acids Chemical class 0.000 description 1
235000021391 short chain fatty acids Nutrition 0.000 description 1
238000004904 shortening Methods 0.000 description 1
230000011664 signaling Effects 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
201000002859 sleep apnea Diseases 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
229940005550 sodium alginate Drugs 0.000 description 1
229910001467 sodium calcium phosphate Inorganic materials 0.000 description 1
CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
229940080313 sodium starch Drugs 0.000 description 1
239000012453 solvate Substances 0.000 description 1
238000003797 solvolysis reaction Methods 0.000 description 1
239000004334 sorbic acid Substances 0.000 description 1
235000010199 sorbic acid Nutrition 0.000 description 1
229940075582 sorbic acid Drugs 0.000 description 1
208000018198 spasticity Diseases 0.000 description 1
241000894007 species Species 0.000 description 1
208000020431 spinal cord injury Diseases 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000007858 starting material Substances 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
TYFQFVWCELRYAO-UHFFFAOYSA-L suberate(2-) Chemical compound [O-]C(=O)CCCCCCC([O-])=O TYFQFVWCELRYAO-UHFFFAOYSA-L 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
150000003871 sulfonates Chemical class 0.000 description 1
150000003457 sulfones Chemical class 0.000 description 1
150000003460 sulfonic acids Chemical class 0.000 description 1
230000006103 sulfonylation Effects 0.000 description 1
238000005694 sulfonylation reaction Methods 0.000 description 1
HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 1
150000003462 sulfoxides Chemical class 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical class ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
OBTWBSRJZRCYQV-UHFFFAOYSA-N sulfuryl difluoride Chemical class FS(F)(=O)=O OBTWBSRJZRCYQV-UHFFFAOYSA-N 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
230000007428 synaptic transmission, GABAergic Effects 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000000454 talc Substances 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
229940095064 tartrate Drugs 0.000 description 1
BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 description 1
YTJJIMVZMKKETR-UHFFFAOYSA-N tert-butyl 4-phenoxybutanoate Chemical compound CC(C)(C)OC(=O)CCCOC1=CC=CC=C1 YTJJIMVZMKKETR-UHFFFAOYSA-N 0.000 description 1
JJMAJUGXVGQGTB-UHFFFAOYSA-N tert-butyl 6-phenylhexanoate Chemical compound CC(C)(C)OC(=O)CCCCCC1=CC=CC=C1 JJMAJUGXVGQGTB-UHFFFAOYSA-N 0.000 description 1
MPCQRNOVFYBCTQ-UHFFFAOYSA-N tert-butyl n-(3-iodophenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=CC(I)=C1 MPCQRNOVFYBCTQ-UHFFFAOYSA-N 0.000 description 1
CQKAPARXKPTKBK-UHFFFAOYSA-N tert-butylazanium;bromide Chemical compound Br.CC(C)(C)N CQKAPARXKPTKBK-UHFFFAOYSA-N 0.000 description 1
125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
150000003512 tertiary amines Chemical class 0.000 description 1
238000012360 testing method Methods 0.000 description 1
FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
238000004809 thin layer chromatography Methods 0.000 description 1
150000003568 thioethers Chemical class 0.000 description 1
229930192474 thiophene Natural products 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000003354 tissue distribution assay Methods 0.000 description 1
238000003325 tomography Methods 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
CFOAUYCPAUGDFF-UHFFFAOYSA-N tosmic Chemical compound CC1=CC=C(S(=O)(=O)C[N+]#[C-])C=C1 CFOAUYCPAUGDFF-UHFFFAOYSA-N 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
108010072897 transcription factor Brn-2 Proteins 0.000 description 1
230000037317 transdermal delivery Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000000844 transformation Methods 0.000 description 1
230000008733 trauma Effects 0.000 description 1
LIHSDQNZUXUECH-UHFFFAOYSA-N tributyl-(5-pyridin-2-yl-1,3-oxazol-2-yl)stannane Chemical compound O1C([Sn](CCCC)(CCCC)CCCC)=NC=C1C1=CC=CC=N1 LIHSDQNZUXUECH-UHFFFAOYSA-N 0.000 description 1
CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Substances C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 description 1
CMSYDJVRTHCWFP-UHFFFAOYSA-N triphenylphosphane;hydrobromide Chemical compound Br.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 CMSYDJVRTHCWFP-UHFFFAOYSA-N 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
229940035893 uracil Drugs 0.000 description 1
229940005605 valeric acid Drugs 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
230000009278 visceral effect Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
239000011995 wilkinson's catalyst Substances 0.000 description 1
UTODFRQBVUVYOB-UHFFFAOYSA-P wilkinson's catalyst Chemical compound [Cl-].C1=CC=CC=C1P(C=1C=CC=CC=1)(C=1C=CC=CC=1)[Rh+](P(C=1C=CC=CC=1)(C=1C=CC=CC=1)C=1C=CC=CC=1)P(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 UTODFRQBVUVYOB-UHFFFAOYSA-P 0.000 description 1
229940071104 xylenesulfonate Drugs 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1

JP2010510368A 2007-05-31 2008-05-30 脂肪酸アミドヒドロラーゼの三環系阻害剤 Pending JP2010533645A (ja)